Guardian Pharmacy Services, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.46% | 19.66% | 13.53% | 15.58% | 18.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.46% | 19.66% | 13.53% | 15.58% | 18.65% |
| Cost of Revenue | 19.86% | 20.41% | 13.00% | 16.08% | 20.40% |
| Gross Profit | 22.95% | 16.64% | 15.64% | 13.62% | 11.90% |
| SG&A Expenses | 194.24% | 182.78% | 82.70% | 2.15% | -52.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.10% | 55.72% | 20.65% | 13.51% | 9.63% |
| Operating Income | -45.62% | -1,552.65% | -50.71% | 93.11% | 142.72% |
| Income Before Tax | 11.42% | -1,410.24% | -53.07% | 100.76% | -5.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.67% | -1,412.75% | -53.07% | 100.76% | -5.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 104.01% | -58.86% | -60.38% | -18.87% | 31.35% |
| Net Income | -0.62% | -897.70% | -68.77% | 293.49% | 2.74% |
| EBIT | -45.62% | -1,552.65% | -50.71% | 93.11% | 142.72% |
| EBITDA | -39.69% | -5,787.65% | -41.85% | 58.33% | 115.29% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.81% | 1.42% | -0.51% | 3.15% |